• Caspase-3/7 Inhibitor I in Translational Apoptosis

  2026-09-08

  Selective, reversible inhibition of caspase-3 and caspase-7 can help translational researchers distinguish executioner-caspase dependence from upstream stress signaling. This article connects the mechanistic selectivity of Caspase-3/7 Inhibitor I with phase-specific Candida krusei apoptosis in bovine mammary epithelial cells, outlining validation strategies, workflow parameters, limitations, and opportunities for cancer research and infectious-disease models.

• Rhodamine B: From Drift Signal to Risk Data

  2026-09-08

  Rhodamine B can do more than reveal where a spray travels: it can help researchers design defensible links between droplet deposition, sampling strategy, and environmental risk. This article translates UAV drift findings into practical fluorescence assay decisions while defining the limits of tracer-based inference.

• CX-5461 Drives DNA Damage in Cervical Cancer

  2026-09-07

  The reference study identifies a mechanistic link between Pol I transcriptional stress, ATM/ATR-associated DNA damage, forced mitotic entry, and mitotic catastrophe in cervical cancer cells. It further shows that CX-5461 can increase cisplatin sensitivity, supporting a combination strategy for treatment-resistant disease while highlighting the need for careful validation beyond cell-based models.

• 2'3'-cGAMP: A STING Assay Control

  2026-09-07

  Explore how 2'3'-cGAMP and the sodium salt form can function as mechanistic controls for cGAS-STING experiments. This article translates recent hepatic ischemia–reperfusion findings into practical assay decisions, controls, and interpretation strategies.

• 2'3'-cGAMP: STING Assay & Nanovaccine Workflows

  2026-09-05

  Learn how to use 2'3'-cGAMP (sodium salt) to build reproducible STING activation assays, compare free and nanoparticle-delivered agonist, and troubleshoot type I interferon induction. The workflow translates recent nanovaccine findings into practical choices for immunotherapy research.

• 2'3'-cGAMP: Practical STING Assay Workflows

  2026-09-04

  Use 2'3'-cGAMP (sodium salt) as a defined STING agonist to benchmark pathway activation, type I interferon induction, and immune-metabolic responses. A workflow built around staged signaling readouts and D2HG biosensors can distinguish direct STING activity from downstream metabolic remodeling.

• Nuclear cGAS and Chk2 Control L1 Retrotransposition

  2026-09-04

  The reference study identifies a nuclear cGAS–CHK2–TRIM41 pathway that limits LINE-1 retrotransposition by promoting ubiquitination and degradation of the essential L1 protein ORF2p. Its findings connect DNA damage signaling with posttranslational control of mobile genetic elements, providing a mechanistic framework for studying genome instability in senescence and cancer.

• Mubritinib–HSA Binding: Mechanistic Insights

  2026-09-03

  This study combines fluorescence spectroscopy, biochemical testing, and molecular docking to define how mubritinib recognizes human serum albumin. Its findings connect moderate site-I binding with local structural changes and inhibition of albumin esterase-like activity, providing a useful pharmacokinetic framework for interpreting this mitochondrial electron transport chain inhibitor.

• Linarin, Cyclin A2, and NSCLC Cell-Cycle Arrest

  2026-09-03

  The reference study combines network pharmacology, cell-based assays, molecular docking, and immunoblotting to identify linarin as an active Herba Patriniae component that suppresses NSCLC growth. Its findings associate linarin with G0/G1 arrest, senescence, and apoptosis through reduced CCNA2, CCNB1, and CHEK1 signaling, including in models with different p53 status.

• Ceftolozane Sulfate: From PBP3 to PK/PD

  2026-09-02

  Ceftolozane sulfate offers translational researchers a mechanistically defined route from PBP-directed cell-wall inhibition to exposure-driven antibacterial decisions. This thought-leadership guide shows how to connect susceptibility testing, resistant-pathogen panels, neutropenic infection models, and PK/PD interpretation while preserving the distinction between a research reagent and the clinical ceftolozane/tazobactam combination.

• a-MSH, amide: Assay Workflows for Pigmentation

  2026-09-02

  Use a-MSH, amide as a defined melanocortin challenge reagent for reproducible melanin synthesis modulation, receptor pharmacology, and anti-inflammatory peptide research. The workflow separates pathway activation from test-agent effects, helping researchers distinguish genuine anti-melanogenic activity from toxicity or assay interference.

• CBX2, HDAC1, and Tumor Immunogenicity

  2026-09-01

  The reference study identifies a noncanonical CBX2–RACK1–HDAC1 corepressor complex that suppresses interferon-stimulated genes and reduces tumor immunogenicity independently of canonical polycomb repression. Its genetic, molecular, and immune-model evidence links CBX2 abundance with immune evasion and weaker responses to anti-PD-1 or adoptive T-cell therapy, positioning CBX2 as a potential immunotherapy biomarker and mechanistic target.

• Proteomimetics Target the SARS-CoV-2 S-RBD/hACE2 Interface

  2026-09-01

  The reference study uses structure-guided alanine mutagenesis and conformational constraint to build proteomimetics that reproduce two discontinuous hACE2 recognition elements on the SARS-CoV-2 Spike receptor-binding domain. Its lead compound, 28, disrupted S-RBD/hACE2 binding, inhibited pseudovirus entry, and showed lung epithelial stability with low permeability, providing a proof of concept for targeting broad, shallow protein–protein interfaces.

• Tranexamic Acid: Fibrinolysis Research Workflow

  2026-08-31

  Translate Tranexamic Acid biology into reproducible clot-stability, plasmin, and neutrophil–endothelial workflows. This guide also shows how the antifibrinolytic agent can be evaluated in advanced wound-dressing prototypes while separating TXA-specific effects from NO- and propolis-mediated antibacterial activity.

• Streptavidin-FITC for Translational Trafficking

  2026-08-31

  Streptavidin-FITC is more than a fluorescent detection reagent: its high-affinity biotin interaction can convert molecular labeling into a practical readout of intracellular trafficking. This thought-leadership guide connects assay design, LNP mechanism, and translational decision-making while defining the limits of fluorescence-based interpretation.

7980 records 1/532 page Next 12345 下5页 Last page